Browsing: CBD

The agency has quietly sent a CBD compliance and enforcement policy to the White House for review, a move that could bring long-overdue standards to a…

Do you ever feel like you are going through a mist? You can’t move fast and don’t know what’s ahead. Every turn feels risky. You might…

Two non-psychoactive cannabis compounds, cannabidiol (CBD) and cannabigerol (CBG), could offer new treatment options for metabolic dysfunction-associated steatotic liver disease (MASLD), according to research published in…

Ananda Pharma has cleared the final regulatory hurdle needed to begin its ENDOCAN Phase 2 clinical trial, receiving approval from the MHRA and NHS Health Research…

You don’t have to be tired after work, but here you are, mentally drained and physically unable to do much, just sitting and scrolling through your…